524414 NORRIS

Norris Medicines Share Price

 

 

Start SIP in NORRIS

Start SIP

Performance

  • Low
  • ₹15
  • High
  • ₹16
  • 52 Week Low
  • ₹14
  • 52 Week High
  • ₹25
  • Open Price₹15
  • Previous Close₹16
  • Volume1,193

Investment Returns

  • Over 1 Month + 9.5%
  • Over 3 Month -5.19%
  • Over 6 Month -9.4%
  • Over 1 Year -6.53%

Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!

Invest Now

Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -10.3
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 16
  • P/B Ratio
  • -1
  • Average True Range
  • 1.08
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.14
  • RSI
  • 49.84
  • MFI
  • 75.83

Norris Medicines Financials

Norris Medicines Technicals

EMA & SMA

Current Price
₹15.90
-0.05 (-0.31%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹15.96
  • 50 Day
  • ₹15.94
  • 100 Day
  • ₹16.27
  • 200 Day
  • ₹16.80

Resistance and Support

15.49 Pivot Speed
  • R3 17.75
  • R2 16.86
  • R1 16.38
  • S1 15.01
  • S2 14.12
  • S3 13.64

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines has an operating revenue of Rs. 7.28 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -20% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Norris Medicines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-28 Audited Results
2025-02-13 Quarterly Results & Others Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters.
2024-11-14 Quarterly Results

Norris Medicines F&O

Norris Medicines Shareholding Pattern

34%
0.01%
0.06%
20.78%
45.15%

Norris Medicines FAQs

Norris Medicines share price is ₹15 As on 02 January, 2026 | 09:05

The Market Cap of Norris Medicines is ₹15.9 Cr As on 02 January, 2026 | 09:05

The P/E ratio of Norris Medicines is -10.3 As on 02 January, 2026 | 09:05

The PB ratio of Norris Medicines is -1 As on 02 January, 2026 | 09:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23